Tandem Diabetes Care, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Tandem Diabetes Care, Inc.
- Regulatory records
- 1
- Linked recall entries
- 9
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Tandem Diabetes Care, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Apr 24, 2026 to Apr 24, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QJI appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 12400 High Bluff Dr., San Diego, CA, 92130, US. Recorded on K260429, decision dated Apr 24, 2026.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Recalls linked to this firm
MedtechLedger links 9 FDA enforcement entries through the recorded recalling firm or an exact submission number published in FDA’s recall data. 5 Class I, 4 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| Tandem Diabetes Care, Inc. | Class I | Nov 11, 2026 | FDA | |
| Tandem Diabetes Care, Inc. | Class II | Oct 7, 2026 | FDA | |
| Tandem Diabetes Care, Inc. | Class II | Apr 1, 2026 | FDA | |
| Tandem Diabetes Care, Inc. | Class I | Nov 12, 2025 | FDA | |
| Tandem Diabetes Care, Inc. | Class II | Oct 29, 2025 | FDA | |
| Tandem Diabetes Care, Inc. | Class II | Oct 1, 2025 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Search the firm’s recall recordsSource updated Nov 11, 2026. Retrieved Nov 21, 2026.
Regulatory record history
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Control-IQ+ technologyK260429 | Tandem Diabetes Care, Inc. | 510(k) clearance | Apr 24, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.





